The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
Abstract
Epithelial neuroendocrine tumors (NETs) have been the subject of much debate regarding their optimal classification. Although multiple systems of nomenclature, grading, and staging have been proposed, none has achieved universal acceptance. To help define the underlying common features of these classification systems and to identify the minimal pathology data that should be reported to ensure consistent clinical management and reproducibility of data from therapeutic trials, a multidisciplinary team of physicians interested in NETs was assembled. At a group meeting, the participants discussed a series of "yes" or "no" questions related to the pathology of NETs and the minimal data to be included in the reports. After discussion, anonymous votes were taken, using the Delphic principle that 80% agreement on a vote of either yes or no would define a consensus. Questions that failed to achieve a consensus were rephrased once or twice and discussed, and additional votes were taken. Of 108 questions, 91 were answerable either yes or no by more than 80% of the participants. There was agreement about the importance of proliferation rate for tumor grading, the landmarks to use for staging, the prognostic factors assessable by routine histology that should be reported, the potential for tumors to progress biologically with metastasis, and the current status of advanced immunohistochemical and molecular testing for treatment-related biomarkers. The lack of utility of a variety of immunohistochemical stains and pathologic findings was also agreed upon. A consensus could not be reached for the remaining 17 questions, which included both minor points related to extent of disease assessment and some major areas such as terminology, routine immunohistochemical staining for general neuroendocrine markers, use of Ki67 staining to assess proliferation, and the relationship of tumor grade to degree of differentiation. On the basis of the results of the Delphic voting, a minimum pathology data set was developed. Although there remains disagreement among experts about the specific classification system that should be used, there is agreement about the fundamental pathology data that should be reported. Examination of the areas of disagreement reveals significant opportunities for collaborative study to resolve unanswered questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Self-citationAJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Consensus methods: characteristics and guidelines for use
Fink, A., Kosecoff, J., Chassin, M., & Brook, R. H. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.9.979 · Cited by 2,089
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
The Delphi technique as a forecasting tool: issues and analysis
Rowe, G., & Wright, G. (1999) · International Journal of Forecasting · doi:10.1016/s0169-2070(99)00018-7 · Cited by 1,789
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationPathology and Genetics of Tumours of the Digestive System
(2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01219.x · Cited by 1,314
Pathology and genetics of tumours of endocrine organs
DeLellis, R. A. (2004) · Cited by 1,122
Rindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Self-citationCurrent Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
Self-citationTravis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S., Jacobs, C., Mares, J. E., Landgraf, A. N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7858 · Cited by 649
Self-citationRenal Medullary Carcinoma The Seventh Sickle Cell Nephropathy
Davis, C. J., Mostofi, F. K., & Sesterhenn, I. A. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199501000-00001 · Cited by 599
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Self-citationPape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Self-citationHochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Self-citationPanzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0017 · Cited by 384
Self-citationKulke, M. H., Hornick, J. L., Frauenhoffer, C., Hooshmand, S., Ryan, D. P., Enzinger, P. C., Meyerhardt, J. A., Clark, J. W., Stuart, K., Fuchs, C. S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1476 · Cited by 381
Self-citationSmall Cell Carcinoma of the Prostate: A Morphologic and Immunohistochemical Study of 95 Cases
Wang, W., & Epstein, J. I. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318058a96b · Cited by 375
Pathology and genetics: Tumours of the digestive system
Haboubi, N. (2000) · Surgical Oncology · doi:10.1016/s0960-7404(01)00003-2 · Cited by 374
Volante, M., Brizzi, M. P., Faggiano, A., Rosa, S. L., Rapa, I., Ferrero, A., Mansueto, G., Righi, L., Garancini, S., Capella, C., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800954 · Cited by 339
Papotti, M., Bongiovanni, M., Volante, M., Allìa, E., Landolfi, S., Helboe, L., Schindler, M., Cole, S., & Bussolati, G. (2002) · Virchows Archiv · doi:10.1007/s00428-002-0609-x · Cited by 330
Cheuk, W., Kwan, M. Y., Suster, S., & Chan, J. K. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0228-ifttfa · Cited by 277
Self-citationMidgut neuroendocrine tumours with liver metastases: results of the UKINETS study
Ahmed, A., Turner, G., King, B., Jones, L., Culliford, D., McCance, D., Ardill, J., Johnston, B. T., Poston, G., Rees, M., et al. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-09-0042 · Cited by 274
Pelosi, G., Bresaola, E., Bogina, G., Pasini, F., Rodella, S., Castelli, P., Iacono, C., Serio, G., & Zamboni, G. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90303-2 · Cited by 267
Prognostic criteria in nonfunctioning pancreatic endocrine tumours
La Rosa, S., Capella, C., Sessa, F., Riva, C., Leone, B. E., Klersy, C., Rindi, G., & Solcia, E. (1996) · Virchows Archiv · doi:10.1007/bf00198436 · Cited by 246
Self-citationBURKE, A. P., Thomas, R. M., Elsayed, A. M., et al. (1997) · PubMed · Cited by 244
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
Modlin, I. M., Moss, S. F., Chung, D. C., Jensen, R. T., & Snyderwine, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn275 · Cited by 224
Self-citationAnlauf, M., Schlenger, R., Perren, A., Bauersfeld, J., Koch, C. A., Dralle, H., Raffel, A., Knoefel, W. T., Weihe, E., Ruszniewski, P., et al. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000194044.01104.25 · Cited by 223
Van Essen, M., Krenning, E. P., De Jong, M., Valkema, R., & Kwekkeboom, D. J. (2007) · Acta Oncologica · doi:10.1080/02841860701441848 · Cited by 221
Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases
Burke, A. P., Thomas, R. M., Elsayed, A. M., & Sobin, L. H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970315)79:6<1086::aid-cncr5>3.0.co;2-e · Cited by 212
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors
Klöppel, G., Rindi, G., Anlauf, M., Perren, A., & Komminoth, P. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0461-0 · Cited by 190
Self-citationKoura, A. N., Giacco, G. G., Curley, S. A., Skibber, J. M., Feig, B. W., & Ellis, L. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7<1294::aid-cncr4>3.0.co;2-h · Cited by 167
Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors
Vilar, E., Salazar, R., Pérez-García, J., Cortes, J., Öberg, K., & Tabernero, J. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0074 · Cited by 161
Self-citationNovel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas
Leja, J., Essaghir, A., Essand, M., Wester, K., öberg, K., Tötterman, T. H., Lloyd, R., Vasmatzis, G., Demoulin, J.-B., & Giandomenico, V. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.174 · Cited by 160
Self-citationIslet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
Schmitt, A. M., Riniker, F., Anlauf, M., Schmid, S., Soltermann, A., Moch, H., Heitz, P. U., Klöppel, G., Komminoth, P., & Perren, A. A. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158a397 · Cited by 159
Kytölä, S. I., Höög, A., Nord, B., Cedermark, B., Frisk, T., Larsson, C., & Kjellman, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64136-3 · Cited by 154
Rigaud, G., Missiaglia, E., Moore, P. S., Zamboni, G., Falconi, M., Talamini, G., Pesci, A., Baron, A., Lissandrini, D., Rindi, G., et al. (2001) · PubMed · Cited by 150
Self-citationKlöppel, G., & Anlauf, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.010 · Cited by 129
Usefulness of CDX2 and TTF-1 in Differentiating Gastrointestinal From Pulmonary Carcinoids
Saqi, A., Alexis, D., Remotti, F., & Bhagat, G. (2005) · American Journal of Clinical Pathology · doi:10.1309/ukn6-pvrk-xhg4-22da · Cited by 128
High-Grade Neuroendocrine Carcinoma of the Ampulla of Vater
Nassar, H., Albores‐Saavedra, J., & Klimstra, D. S. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157974.05397.4f · Cited by 118
Self-citationSolcia, E., Fiocca, R., Villani, L., Luinetti, O., & Capella, C. (1995) · PubMed · Cited by 117
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours
Öberg, K., & Eriksson, B. K. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.016 · Cited by 116
Molecular targeted therapy for carcinoid and islet-cell carcinoma
Yao, J. C. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.01.006 · Cited by 115
Self-citationCytokeratin 19 Is a Powerful Predictor of Survival in Pancreatic Endocrine Tumors
Deshpande, V., Castillo, C. F. F.-D., Muzikansky, A., Deshpande, A., Zukerberg, L. R., Warshaw, A. L., & Lauwers, G. Y. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000135525.11566.b4 · Cited by 114
Self-citationJamali, M., & Chetty, R. (2008) · Endocrine Pathology · doi:10.1007/s12022-008-9044-0 · Cited by 100
Self-citationCouvelard, A., Deschamps, L., Ravaud, P., Baron, G., Sauvanet, A., Hentic, O., Colnot, N., Paradis, V., Belghiti, J., Bédossa, P., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.177 · Cited by 92
Plöckinger, U., & Wiedenmann, B. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.01.002 · Cited by 85
Self-citationHistologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms
Cho, C. S., Labow, D. M., Tang, L. H., Klimstra, D. S., Loeffler, A. G., LEVERSON, G. E., Fong, Y., Jarnagin, W. R., D'Angelica, M. I., Weber, S. M., et al. (2008) · Cancer · doi:10.1002/cncr.23523 · Cited by 81
Self-citationArnold, R. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.03.006 · Cited by 80
Öberg, K., & Jelić, S. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp158 · Cited by 80
Lejeune, M., Jaén, J., Pons, L. E., López, C., Salvadó-Usach, T., Bosch, R., García, M., Escrivá, P., Baucells, J., Cugat, X., et al. (2008) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.00910.x · Cited by 76
Pancreatic Endocrine Microadenomatosis in Patients With von Hippel-Lindau Disease
Périgny, M., Hammel, P. R., Corcos, O., LaRochelle, O., Giraud, S., Richard, S., Sauvanet, A., Belghiti, J., Ruszniewski, P. B., Bédossa, P., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181967992 · Cited by 71
Chatzipantelis, P., Konstantinou, P., Kaklamanos, M., Apostolou, G., & Salla, C. (2009) · Cancer Cytopathology · doi:10.1002/cncy.20025 · Cited by 69
Nikou, G. C., Lygidakis, N. J., Toubanakis, C., Pavlatos, S., Tseleni‐Balafouta, S., Giannatou, E., Mallas, E., & Safioleas, M. C. (2005) · PubMed · Cited by 64
Drozdov, I. A., Kidd, M. S., Nadler, B., Camp, R. L., Mane, S., Hauso, Ø., Gustafsson, B. I., & Modlin, I. M. (2009) · Cancer · doi:10.1002/cncr.24180 · Cited by 62
Self-citationPharmacotherapy of neuroendocrine cancers
Modlin, I., Kidd, M. S., Drozdov, I. A., Siddique, Z.-L., & Gustafsson, B. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2617 · Cited by 59
Self-citationA Proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients
Landry, C. S., Brock, G. N., Scoggins, C. R., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0192-8 · Cited by 58
Neuroendocrine Neoplasms of the Mediastinum
Suster, S. M., & Moran, C. A. (2001) · Pathology Patterns Reviews · doi:10.1309/l38w-8p9x-x142-3n78 · Cited by 51
Self-citationMolecular Targeted Therapy for Neuroendocrine Tumors
Yao, J. C., & Hoff, P. M. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.001 · Cited by 40
Self-citationÖberg, K., & Jelic, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn117 · Cited by 35
The term "carcinoid" is a misnomer: the evidence based on local invasion
Soga, J. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-15 · Cited by 33
Somatostatin analog octreotide LAR®in gastro–entero–pancreatic tumors
Öberg, K. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.26 · Cited by 33
Dixon, E., Armstrong, C., Maddern, G. J., Sutherland, F. R., Hemming, A. W., Wei, A. C.-C., Sherman, M., Moore, M. J., McKay, A. M., Urbach, D. R., et al. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.084 · Cited by 29
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
Reidy‐Lagunes, D. L., Tang, L. H., & Saltz, L. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/ncponc1326 · Cited by 28
Self-citationTreatment options for metastatic neuroendocrine tumors
Phan, A. T., Yao, J. C., & Evans, D. B. (2008) · Surgery · doi:10.1016/j.surg.2008.10.003 · Cited by 6
Self-citation
Cited by
Rindi, G., Klimstra, D. S., Abedi-Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E., Busam, K. J., de Krijger, R. R., Dietel, M., El-Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,163
Self-citationKlimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Self-citationThe Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Lawrence, B., Gustafsson, B. I., Chan, A., Svejda, B., Kidd, M., & Modlin, I. M. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.005 · Cited by 861
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationNeuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Metadata
- Authors
- Klimstra, D. S., Modlin, I. R., Adsay, N. V., Chetty, R., Deshpande, V., Gönen, M., Jensen, R. T., Kidd, M., Kulke, M. H., Lloyd, R. V., Moran, C., Moss, S. F., Oberg, K., O'Toole, D., Rindi, G., Robert, M. E., Suster, S., Tang, L. H., Tzen, C.-Y., Washington, M. K., Wiedenmann, B., & Yao, J.
- Venue
- American Journal of Surgical Pathology
- Published
- 2010-03
- Volume
- 34
- Issue
- 3
- Pages
- 300-313
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2010084014
- Cited by
- 351
- References
- 69
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.